Apogee Therapeutics, Inc. - 8-K Filing
Apogee Therapeutics agreed to merge with Andor Merger Co., a subsidiary of AbbVie Inc., under terms where each share will receive $135.11 in cash, effective upon shareholder approval and regulatory clearances by December 18, 2026. (Items: 1.01 Entry into a Material Definitive Agreement, 5.07 Submission of Matters to a Vote of Security Holders, 7.01 Regulation FD Disclosure, 8.01 Other Events)
Tickers: $APGE